CENPM and hepatocellular carcinoma: Our study found that the expression of CENPM was significantly increased in patients with hepatocellular carcinoma, and was related to a variety of clinical features, its correlation with the level of immune infiltration and poor prognosis, so CENPM may become a useful biomarker for the prognosis of patients with liver cancer.